The takeover is just the next step.
There is overlap between Healius and Vision Eye institute in day surgeries and synergies.
I suspect after Healius. Jangho will go after MVF next as IVF uses a bit of diagnostics such as ultrasounds and other genetics tests.
I think Jangho has a clear strategy in healthcare sector in Australia. Not to mention it provides a way to consolidate healthcare in China.
Imagine your a chinese doctor who will be given an opportunity to migrate to australia after years of loyal service in China.
- Forums
- ASX - By Stock
- HLS
- Ann: Non-binding indicative proposal for acquisition of Healius
Ann: Non-binding indicative proposal for acquisition of Healius, page-32
-
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HLS (ASX) to my watchlist
|
|||||
Last
$1.47 |
Change
0.003(0.17%) |
Mkt cap ! $1.067B |
Open | High | Low | Value | Volume |
$1.47 | $1.48 | $1.46 | $599.5K | 408.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 9120 | $1.47 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.47 | 9271 | 26 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
15 | 10122 | 1.465 |
10 | 21264 | 1.460 |
12 | 84600 | 1.455 |
8 | 46277 | 1.450 |
4 | 144006 | 1.445 |
Price($) | Vol. | No. |
---|---|---|
1.470 | 8968 | 23 |
1.475 | 19445 | 13 |
1.480 | 34857 | 14 |
1.485 | 26358 | 10 |
1.490 | 12729 | 7 |
Last trade - 11.58am 16/07/2024 (20 minute delay) ? |
Featured News
HLS (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online